Trademark Details For QUBALYN (Serial Number 79279473)

  •  Home
  •  Print
QUBALYN
1
6
3
0
Basic Information
Serial Number  United States - USPTO 79279473
Registration Number 6166433
Mark
QUBALYN
Filing Date Jan-13-2020
Status
Registered  
REGISTERED (700)
REGISTERED
Attorney Name
TTAB
0


  • GLAXO GROUP LIMITED


005Pharmaceuticals

U.S Class(es): 005, 006, 018, 044, 046, 051, 052

Class Status: Active





Correspondences

NameLegal Brand Protection, GSK
AddressLegal Brand Protection, GSK GSK House, 980 Great West Road BRENTFORD Middlesex TW8 9GS UNITED KINGDOM

Prosecution History

USPTO 
DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Feb-27-2020SN ASSIGNED FOR SECT 66A APPL FROM IB   REPRM
Mar-02-2020LIMITATION FROM ORIGINAL APPLICATION ENTERED   LIMII
Mar-04-2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED   NWOSI
Mar-10-2020APPLICATION FILING RECEIPT MAILED   MAFRO
Mar-15-2020ASSIGNED TO EXAMINER   DOCKD
Mar-19-2020APPROVED FOR PUB - PRINCIPAL REGISTER   CNSAO
Apr-01-2020NOTICE OF PUBLICATION   NPUBO
Apr-21-2020PUBLISHED FOR OPPOSITION   PUBOA
May-20-2020EXTENSION OF TIME TO OPPOSE RECEIVED   ETOFT
Aug-30-2020EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED   ETOPT
Oct-06-2020REGISTERED-PRINCIPAL REGISTER   R.PRA
Nov-01-2020LIMITATION OF GOODS RECEIVED FROM IB   LIMGM
Nov-05-2020GRANT OF PROTECTION CREATED, TO BE SENT TO IB   GPARP
Nov-18-2020FINAL DISPOSITION PROCESSED   FIMPP
Nov-18-2020FINAL DISPOSITION NOTICE SENT TO IB   FICSP
Dec-05-2020NOTIFICATION PROCESSED BY IB   GPNXP
Mar-28-2021CORRECTION UNDER SECTION 7 ¿ PROCESSED   COC.O
Mar-29-2021LIMITATION FROM THE IB EXAMINED AND ENTERED   LIMEI
May-04-2021CORRECTION UNDER SECTION 7 ¿ PROCESSED   COC.O
Jan-04-2022PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED   INPRP
May-06-2022INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE   INNAR
Aug-11-2023CHANGE OF NAME/ADDRESS REC'D FROM IB   ADCHM